256 related articles for article (PubMed ID: 19696650)
1. Full donor chimerism using stem-cell transplantation for tolerance induction in the human leukocyte antigen-matched liver transplant setting.
Kim SY; Kim DW; Choi JY; Kim DG; Min WS; Lee JW; Kim CC
Transplantation; 2009 Aug; 88(4):601-3. PubMed ID: 19696650
[No Abstract] [Full Text] [Related]
2. Embryonic stem cell derived and adult hematopoietic stem cell transplantation for tolerance induction in a renal allograft recipient:--a case report.
Trivedi HL; Mishra VV; Vanikar AV; Modi PR; Shah VR; Shah PR; Firoz A
Transplant Proc; 2006 Nov; 38(9):3103-8. PubMed ID: 17112910
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
[TBL] [Abstract][Full Text] [Related]
4. Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Sobecks RM; Ball EJ; Askar M; Theil KS; Rybicki LA; Thomas D; Brown S; Kalaycio M; Andresen S; Pohlman B; Dean R; Sweetenham J; Macklis R; Bernhard L; Cherni K; Copelan E; Maciejewski JP; Bolwell BJ
Bone Marrow Transplant; 2008 Apr; 41(8):709-14. PubMed ID: 18195688
[TBL] [Abstract][Full Text] [Related]
5. Chimerism and tolerance induction in kidney transplantation.
Traitanon O; Gallon L
Nephron; 2015; 129(1):34-8. PubMed ID: 25531026
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic chimerism achieved by in utero hematopoietic stem cell injection does not induce donor-specific tolerance for renal allografts in sheep.
Hedrick MH; Rice HE; MacGillivray TE; Bealer JF; Zanjani ED; Flake AW
Transplantation; 1994 Jul; 58(1):110-1. PubMed ID: 7913560
[No Abstract] [Full Text] [Related]
7. Chimerism and tolerance in a recipient of a deceased-donor liver transplant.
Alexander SI; Smith N; Hu M; Verran D; Shun A; Dorney S; Smith A; Webster B; Shaw PJ; Lammi A; Stormon MO
N Engl J Med; 2008 Jan; 358(4):369-74. PubMed ID: 18216357
[TBL] [Abstract][Full Text] [Related]
8. Hurdles to the induction of tolerogenic mixed chimerism.
Pilat N; Klaus C; Schwaiger E; Wekerle T
Transplantation; 2009 May; 87(9 Suppl):S79-84. PubMed ID: 19424016
[TBL] [Abstract][Full Text] [Related]
9. Tolerance induction in HLA disparate living donor kidney transplantation by facilitating cell-enriched donor stem cell Infusion: The importance of durable chimerism.
Leventhal JR; Ildstad ST
Hum Immunol; 2018 May; 79(5):272-276. PubMed ID: 29409743
[TBL] [Abstract][Full Text] [Related]
10. [Transplant tolerance through mixed chimerism].
Zuber J
Nephrol Ther; 2017 Apr; 13 Suppl 1():S127-S130. PubMed ID: 28577733
[TBL] [Abstract][Full Text] [Related]
11. [A novel quantitative approach to donor chimerism and its clinical effect after allogenic hematopoietic stem cell transplantation].
Zhen ZJ; Fang JP; Li CK
Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):540-1. PubMed ID: 17044983
[No Abstract] [Full Text] [Related]
12. Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis.
Hashimoto T; Sugawara Y; Makuuchi M
Liver Transpl; 2007 Jun; 13(6):938-9. PubMed ID: 17538993
[No Abstract] [Full Text] [Related]
13. Long-term follow-up of donor chimerism and tolerance after human liver transplantation.
Ayala R; Grande S; Albizua E; Crooke A; Meneu JC; Moreno A; Pérez B; Gilsanz F; Moreno E; Martínez-Lopez J
Liver Transpl; 2009 Jun; 15(6):581-91. PubMed ID: 19479801
[TBL] [Abstract][Full Text] [Related]
14. Tolerance to liver allograft after allogeneic hematopoietic cell transplantation for severe aplastic anemia from the same HLA-matched sibling donor.
Sun H; Therapondos G; Lipton J; Gupta V
Bone Marrow Transplant; 2012 Aug; 47(8):1128-30. PubMed ID: 22080972
[No Abstract] [Full Text] [Related]
15. Immunological reconstitution: chimerism and the mechanisms for tolerance following transplantation of hemopoietic cells.
Ascensao Jl
Blood Cells; 1991; 17(2):403-6. PubMed ID: 1680509
[No Abstract] [Full Text] [Related]
16. Clinical experience with mixed chimerism to induce transplantation tolerance.
Fehr T; Sykes M
Transpl Int; 2008 Dec; 21(12):1118-35. PubMed ID: 18954364
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantation.
Orti G; Lowdell M; Fielding A; Samuel E; Pang K; Kottaridis P; Morris E; Thomson K; Peggs K; Mackinnon S; Chakraverty R
Transplantation; 2009 Dec; 88(11):1312-8. PubMed ID: 19996931
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of T-cell prolymphocytic leukemia with full-intensity conditioning followed by matched unrelated donor allogeneic stem cell transplantation.
Kruspe RC; Ashraf KK; Foran JM; Salzman DE; Reddy VV; Vaughan WP
Clin Adv Hematol Oncol; 2007 Nov; 5(11):882-4; discussion 884. PubMed ID: 18185486
[No Abstract] [Full Text] [Related]
19. Macrochimerism and clinical transplant tolerance.
Scandling JD; Busque S; Lowsky R; Shizuru J; Shori A; Engleman E; Jensen K; Strober S
Hum Immunol; 2018 May; 79(5):266-271. PubMed ID: 29330112
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation.
Danzer M; Polin H; Pröll J; Haunschmid R; Hofer K; Stabentheiner S; Hackl C; Kasparu H; König J; Hauser H; Binder M; Weiss R; Gabriel C; Krieger O
Transplantation; 2009 Aug; 88(4):528-32. PubMed ID: 19696636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
